Literature DB >> 6489524

Malonyl CoA inhibition of carnitine palmityltransferase in rat heart mitochondria.

D J Paulson, K M Ward, A L Shug.   

Abstract

The effects of malonyl CoA on carnitine palmityltransferase I (CPT-I), fatty acid-supported state 3 respiration, and carnitine reversal of palmityl CoA inhibition of state 3 respiration and of the adenine nucleotide translocator, were studied in isolated rat heart mitochondria. Malonyl CoA was a potent competitive inhibitor of CPT-I with an I50 of 0.8 microM. Fasting did not affect CPT-I activity or the I50 value of malonyl CoA. Malonyl CoA inhibited fatty acid-supported respiration and prevented carnitine from reversing the inhibition of the adenine nucleotide translocator by palmityl CoA. These findings suggest that malonyl CoA may affect fatty acid oxidation in the heart.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6489524     DOI： 10.1016/0014-5793(84)81201-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Metabolic alterations induce oxidative stress in diabetic and failing hearts: different pathways, same outcome.

Authors:  David Roul; Fabio A Recchia
Journal:  Antioxid Redox Signal       Date:  2015-04-30       Impact factor: 8.401

2.  Integrative metabolome and transcriptome profiling reveals discordant energetic stress between mouse strains with differential sensitivity to acrolein-induced acute lung injury.

Authors:  James P Fabisiak; Mario Medvedovic; Danny C Alexander; Jonathan E McDunn; Vincent J Concel; Kiflai Bein; An Soo Jang; Annerose Berndt; Louis J Vuga; Kelly A Brant; Hannah Pope-Varsalona; Richard A Dopico; Koustav Ganguly; Swapna Upadhyay; Qian Li; Zhen Hu; Naftali Kaminski; George D Leikauf
Journal:  Mol Nutr Food Res       Date:  2011-08-08       Impact factor: 5.914

Review 3.  Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series).

Authors:  Sowndramalingam Sankaralingam; Gary D Lopaschuk
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

4.  Carnitine palmitoyltransferase in liver and five extrahepatic tissues in the rat. Inhibition by DL-2-bromopalmitoyl-CoA and effect of hypothyroidism.

Authors:  E D Saggerson; C A Carpenter
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

5.  Different sites of inhibition of carnitine palmitoyltransferase by malonyl-CoA, and by acetyl-CoA and CoA, in human skeletal muscle.

Authors:  S Zierz; A G Engel
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

6.  Carnitine palmitoyltransferase in the heart is controlled by a different mechanism than the hepatic enzyme.

Authors:  G A Cook; M D Lappi
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

Review 7.  Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy.

Authors:  N Fillmore; J Mori; G D Lopaschuk
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 8.  Cardiac Energy Metabolism in Heart Failure.

Authors:  Gary D Lopaschuk; Qutuba G Karwi; Rong Tian; Adam R Wende; E Dale Abel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

9.  Effects of Arsenite Exposure during Fetal Development on Energy Metabolism and Susceptibility to Diet-Induced Fatty Liver Disease in Male Mice.

Authors:  Eric J Ditzel; Thu Nguyen; Patricia Parker; Todd D Camenisch
Journal:  Environ Health Perspect       Date:  2015-07-07       Impact factor: 9.031

10.  Carnitine Supplementation Attenuates Sunitinib-Induced Inhibition of AMP-Activated Protein Kinase Downstream Signals in Cardiac Tissues.

Authors:  Mohamed M Sayed-Ahmed; Badr I Alrufaiq; Ammar Alrikabi; Mashan L Abdullah; Mohamed M Hafez; Othman A Al-Shabanah
Journal:  Cardiovasc Toxicol       Date:  2019-08       Impact factor: 3.231
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.